NewGenIvf (NIVF) Debt to Equity (2024 - 2025)

NewGenIvf (NIVF) posted quarterly Debt to Equity of $0.02 for Q4 2025, up 135.82% YoY from $0.01 in Q4 2024, and down 41.33% sequentially from $0.03 in Q2 2025.

NewGenIvf (NIVF) Debt to Equity (2024 - 2025) Analysis & Trends

NewGenIvf has disclosed Debt to Equity across 2 years of filings, most recently posting $0.02 for Q4 2025.

  • In Q4 2025, Debt to Equity rose 135.82% year-over-year to $0.02; the TTM figure through Dec 2025 stood at $0.02 (up 135.82% YoY), while the FY2025 annual figure was $0.02, up 135.82% from the prior year.
  • Debt to Equity retreated to $0.02 in Q4 2025, from $0.03 in the prior quarter.
  • Over the last five years, Debt to Equity for NIVF reached as high as $0.03 in Q2 2025 and fell as low as -$0.05 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn -16.13
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn 0.11
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn 2.74
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn -22.31
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn 0.78
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn 0.06
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn 0.63
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn 0.05
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn 1.46
10 NewGenIvf 25,304.95 -1.41 Mn 524,025.00 0.02

Historic Data

Download Data
DateValue
Dec 31, 2025 0.02
Jun 30, 2025 0.03
Dec 31, 2024 -0.05